Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1987-11-25
1989-10-24
Hines, Robert V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514555, 514649, 514811, 514813, 564304, 564373, 562597, A61K 31207
Patent
active
048762822
ABSTRACT:
The present invention provides 1-phenyl-(naphthalenyl)alkylamines which are selective inhibitors of serotonin uptake.
REFERENCES:
patent: 3079403 (1963-02-01), Weinstock
patent: 3138639 (1964-06-01), Brossi et al.
patent: 3178477 (1965-04-01), Seeger et al.
patent: 3308157 (1967-03-01), Robertson et al.
patent: 3689504 (1972-09-01), Horrom
patent: 3814750 (1974-06-01), Cross et al.
patent: 3972935 (1976-08-01), Molloy
patent: 4018895 (1977-04-01), Molloy et al.
patent: 4034011 (1977-07-01), Molloy
patent: 4062955 (1977-12-01), Burn et al.
patent: 4194009 (1980-03-01), Molloy et al.
patent: 4207343 (1980-06-01), Lavagnino et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4329356 (1982-05-01), Holland
Clark et al., Journal of Medicinal Chemistry, vol. 22, No. 11, 1373-1379 (1979).
Robertson David W.
Wong David T.
Conrad Robert A.
Eli Lilly and Company
Hines Robert V.
Whitaker Leroy
LandOfFree
1-Phenylalkylamines as selective serotonin uptake inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-Phenylalkylamines as selective serotonin uptake inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Phenylalkylamines as selective serotonin uptake inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1589562